Common variants in Alzheimer’s disease and risk stratification by polygenic risk scoresItziar de Rojas, Alun Meggy, Nancy L. Pedersen et al.|Nature Communications|2021Cited by 345
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J. van der Lee, Estrella Morenas‐Rodríguez, EADB (Alzheimer Disease European DNA biobank) et al.|Acta Neuropathologica|2019Cited by 132
A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer's Disease, Dementia with Lewy-Bodies and Frontotemporal Dementia, and Increases the Likelihood of LongevitySven J. van der Lee, Heinz Wiendl, Olivia J. Conway et al.|SSRN Electronic Journal|2018Cited by 26